185 related articles for article (PubMed ID: 11002541)
1. [Esophageal ulcer due to mesalazine].
López-Cepero Andrada JM; López Silva M; Salado Fuentes M; Benítez Roldán A
Gastroenterol Hepatol; 2000; 23(7):362. PubMed ID: 11002541
[No Abstract] [Full Text] [Related]
2. Cataflam-induced esophageal ulceration.
Isler M; Bahceci M
Am J Gastroenterol; 2001 Apr; 96(4):1300-1. PubMed ID: 11316193
[No Abstract] [Full Text] [Related]
3. [Non-steroidal anti-inflammatory agents and digestive lesions].
Bellanger J; Pointereau-Bellanger A
Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):237-48. PubMed ID: 2694919
[No Abstract] [Full Text] [Related]
4. Oesophageal ulceration associated with ingestion of mefenamic acid capsules.
Katsinelos P; Dimiropoulos S; Vasiliadis T; Fotiadis G; Xiarchos P; Eugenidis N
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1431-2. PubMed ID: 10654808
[No Abstract] [Full Text] [Related]
5. Major gastrointestinal ulceration in association with Piroxicam therapy.
Irving AD; Sadek SA
J R Coll Surg Edinb; 1983 Mar; 28(2):121-2. PubMed ID: 6602880
[No Abstract] [Full Text] [Related]
6. [Drug-induced esophagitis, esophageal ulcer, gastro-duodenal ulcer, and small intestinal ulcer].
Matsuhashi N; Sakurai Y
Nihon Rinsho; 2007 Oct; 65 Suppl 8():504-8. PubMed ID: 18074591
[No Abstract] [Full Text] [Related]
7. NSAIDs-induced digestive hemorrhage and esophageal pseudotumor: a case report.
Sacca' N; Rodino' S; De Medici A; De Siena M; Giglio A
Endoscopy; 1995 Oct; 27(8):632. PubMed ID: 8608768
[No Abstract] [Full Text] [Related]
8. [72-year-old patient with tumor and gastrointestinal bleeding].
Gerber T
Dtsch Med Wochenschr; 2010 Jun; 135(22):1123-4. PubMed ID: 20503138
[No Abstract] [Full Text] [Related]
9. Adult fibrosing colonopathy associated with mesalazine treatment.
Gaia E; Sambatoro A; De Giuli P; Angeli A
Am J Gastroenterol; 2001 Aug; 96(8):2508-9. PubMed ID: 11513205
[No Abstract] [Full Text] [Related]
10. Mesalazine and para-phenylenediamine allergy.
Charles J; Bourrain JL; Tessier A; Lepoittevin JP; Beani JC
Contact Dermatitis; 2004; 51(5-6):313-4. PubMed ID: 15606661
[No Abstract] [Full Text] [Related]
11. Mesalazine-induced reversible infertility in a young male.
Chermesh I; Eliakim R
Dig Liver Dis; 2004 Aug; 36(8):551-2. PubMed ID: 15334777
[TBL] [Abstract][Full Text] [Related]
12. [Chronic renal insufficiency (interstitial nephritis) under mesalazine].
Legoux JL; Labarrière D; Grézard O; Jaltel M; Lagasse JP; Bahallah ML; Maitre F; Causse X
Gastroenterol Clin Biol; 1998; 22(8-9):737-9. PubMed ID: 9823565
[No Abstract] [Full Text] [Related]
13. [Severe chronic interstitial nephritis associated with Crohn's disease, but not with mesalazine?].
Baumer P; Brocard JF; Kohn W; Bedossa P; Charpentier B
Gastroenterol Clin Biol; 1999 Dec; 23(12):1400-2. PubMed ID: 10642629
[No Abstract] [Full Text] [Related]
14. Mesalazine-induced interstitial nephritis.
Skalova S; Dedek P; Pozler O; Podhola M
Ren Fail; 2009; 31(2):159-61. PubMed ID: 19212915
[TBL] [Abstract][Full Text] [Related]
15. [Angioedema in Crohn's disease possibly due to mesalazine].
Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
[No Abstract] [Full Text] [Related]
16. [Thrombopenia during 5-ASA treatment (mesalazine and olsalazine)].
Benoit R; Grobost O; Bichoffe A; Dol L
Gastroenterol Clin Biol; 1999 Mar; 23(3):410-1. PubMed ID: 10384350
[No Abstract] [Full Text] [Related]
17. [Interstitial nephritis associated with mesalazine therapy].
Vuotila M; Ikäheimo R; Pietiläinen T
Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
[No Abstract] [Full Text] [Related]
18. [Mesalazine-induced nephropathy].
Zaragoza Marcet A; Ivorra Cortés J
Rev Esp Enferm Dig; 2001 Aug; 93(8):548. PubMed ID: 11692787
[No Abstract] [Full Text] [Related]
19. Myocarditis by mesalazine with cardiac magnetic resonance imaging.
García-Ferrer L; Estornell J; Palanca V
Eur Heart J; 2009 Apr; 30(8):1015. PubMed ID: 19168869
[No Abstract] [Full Text] [Related]
20. Mesalazine-induced esophageal ulcers. A rare adverse effect.
Díaz Molina RJ; Comesaña Castellar C; García Hernández M; Garrido Durán C; Martínez Ortega MA; Ginard Vicens D
Rev Esp Enferm Dig; 2024 May; 116(5):294-295. PubMed ID: 37350665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
